Description

α-[(3,3-Dimethyl-2-Isopropyloxiranyl)Ethynyl]-α-Methylcyclopentanemethanol is a high-purity, advanced pharmaceutical intermediate characterized by its complex molecular architecture featuring an oxiranyl and ethynyl functional groups. This compound is of significant commercial value for its role in the synthesis of novel, potent active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily sought after by research institutions and manufacturers in the pharmaceutical and fine chemical industries engaged in developing next-generation drug candidates.

Application

• Pharmaceutical Intermediate: A critical building block for the synthesis of novel active pharmaceutical ingredients (APIs), especially in complex molecule development.
• Organic Synthesis Research: Used in academic and industrial R&D for constructing complex molecular architectures and exploring new chemical spaces.
• Fine Chemical Production: Serves as a key precursor in the multi-step synthesis of specialty chemicals and high-value agrochemicals.
• Asymmetric Synthesis: The chiral centers and functional groups make it valuable for developing enantioselective catalysts and chiral auxiliaries.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies and lead optimization for new drug discovery programs.

Basic Information

Product Name	α-[(3,3-Dimethyl-2-Isopropyloxiranyl)Ethynyl]-α-Methylcyclopentanemethanol
CAS No.	63954-68-7
Molecular Formula	C16H26O2
Molecular Weight	250.38 g/mol
Synonyms	α-[(3,3-Dimethyl-2-isopropyloxiran-2-yl)ethynyl]-α-methylcyclopentanemethanol; (3,3-Dimethyl-2-isopropyloxiran-2-yl)ethynyl-methylcyclopentanemethanol; 2-[(1-Hydroxy-1-methylcyclopentyl)ethynyl]-2-isopropyl-3,3-dimethyloxirane; α-Methyl-α-[(3,3-dimethyl-2-isopropyl-2-oxiranyl)ethynyl]cyclopentanemethanol
EINECS	Contact for details

Quality Control

Our production of α-[(3,3-Dimethyl-2-Isopropyloxiranyl)Ethynyl]-α-Methylcyclopentanemethanol adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. The material is manufactured under a quality system compliant with cGMP principles for pharmaceutical intermediates. Each batch is supported by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We are committed to meeting the specific quality requirements of our clients' development and manufacturing processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat sources and incompatible materials. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder or solid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Purity (GC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.